Hamann A - Search Results

1

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L. Toplak H, et al. Among authors: hamann a. Diabetes Obes Metab. 2005 Nov;7(6):699-708. doi: 10.1111/j.1463-1326.2005.00483.x. Diabetes Obes Metab. 2005. PMID: 16219013 Clinical Trial.

2

Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Toplak H, Hamann A, Moore R, Masson E, Gorska M, Vercruysse F, Sun X, Fitchet M. Toplak H, et al. Among authors: hamann a. Int J Obes (Lond). 2007 Jan;31(1):138-46. doi: 10.1038/sj.ijo.0803382. Epub 2006 May 16. Int J Obes (Lond). 2007. PMID: 16703004 Clinical Trial.

3

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.

4

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group. Porta M, et al. Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12. Diabetologia. 2011. PMID: 21225239 Free article. Clinical Trial.

5

Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.

Rosenstock J, Chou HS, Matthaei S, Seidel DK, Hamann A. Rosenstock J, et al. Among authors: hamann a. Diabetes Obes Metab. 2008 Sep;10(10):862-73. doi: 10.1111/j.1463-1326.2007.00815.x. Epub 2008 Jan 14. Diabetes Obes Metab. 2008. PMID: 18201206 Clinical Trial.

6

[Long-term weight reduction. Current therapy approaches in obesity].

Lichtenstein S, Schulz B, Hamann A. Lichtenstein S, et al. Among authors: hamann a. MMW Fortschr Med. 2001 May 24;143(21):28-30, 32-4. MMW Fortschr Med. 2001. PMID: 11420828 German.

7

Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.

Tafel J, Branscheid I, Skwarna B, Schlimme M, Morcos M, Algenstaedt P, Hinney A, Hebebrand J, Nawroth P, Hamann A. Tafel J, et al. Among authors: hamann a. Diabetes Obes Metab. 2004 Nov;6(6):452-5. doi: 10.1111/j.1462-8902.2004.00366.x. Diabetes Obes Metab. 2004. PMID: 15479221

8

Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.

Jabbour SA, Hardy E, Sugg J, Parikh S; Study 10 Group. Jabbour SA, et al. Diabetes Care. 2014;37(3):740-50. doi: 10.2337/dc13-0467. Epub 2013 Oct 21. Diabetes Care. 2014. PMID: 24144654 Clinical Trial.

9

[Pharmacotherapy of obesity].

Hamann A. Hamann A. Internist (Berl). 2008 Jan;49(1):106-13. doi: 10.1007/s00108-007-1981-z. Internist (Berl). 2008. PMID: 18060334 Review. German.

10

[Pharmacotherapy in the treatment of obesity].

Hamann A. Hamann A. MMW Fortschr Med. 2006 Mar 2;148(9):36-8. doi: 10.1007/BF03364581. MMW Fortschr Med. 2006. PMID: 16566392 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page